You are here: Industry Insights > ACE2

News List

Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay americanpharmaceuticalreview
October 26, 2020
Beroni Group has announced successful completion of SARS-CoV-2 pseudovirus neutralization assay in collaboration with GenScript Biotech Corporation. The assay targets on coronavirus-specific nanobodies and tests affinity and efficacy to prevent the ...
Researchers design and test protein that may lead to COVID-19 therapeutic worldpharmanews
August 18, 2020
A novel receptor protein that binds to the SARS-CoV-2 virus and prevents it from entering cells may hold promise for treating COVID-19 and other coronavirus-related diseases, according to research published online Aug. 4 in the journal SCIENCE.
Trial drug can significantly block early stages of COVID-19 in engineered human tissues worldpharmanews
April 07, 2020
An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

Previous page 1 2 Next page